71 related articles for article (PubMed ID: 11229338)
21. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.
Kaina B; Christmann M; Naumann S; Roos WP
DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253
[TBL] [Abstract][Full Text] [Related]
22. MGMT hypermethylation: a prognostic foe, a predictive friend.
Jacinto FV; Esteller M
DNA Repair (Amst); 2007 Aug; 6(8):1155-60. PubMed ID: 17482895
[TBL] [Abstract][Full Text] [Related]
23. Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases.
Nagasaka T; Sharp GB; Notohara K; Kambara T; Sasamoto H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
Clin Cancer Res; 2003 Nov; 9(14):5306-12. PubMed ID: 14614014
[TBL] [Abstract][Full Text] [Related]
24. O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells.
Blough MD; Zlatescu MC; Cairncross JG
Cancer Res; 2007 Jan; 67(2):580-4. PubMed ID: 17234766
[TBL] [Abstract][Full Text] [Related]
25. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
26. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
Pollack IF; Hamilton RL; Sobol RW; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL
J Clin Oncol; 2006 Jul; 24(21):3431-7. PubMed ID: 16849758
[TBL] [Abstract][Full Text] [Related]
27. Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew M; Smith JL; Jass JR; Young J; Leggett BA; Macdonald GA
Oncol Rep; 2007 Apr; 17(4):817-22. PubMed ID: 17342321
[TBL] [Abstract][Full Text] [Related]
28. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.
Esteller M; Risques RA; Toyota M; Capella G; Moreno V; Peinado MA; Baylin SB; Herman JG
Cancer Res; 2001 Jun; 61(12):4689-92. PubMed ID: 11406538
[TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA
Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804
[TBL] [Abstract][Full Text] [Related]
30. Aberrant methylation and loss of expression of O-methylguanine-DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinoma.
Furonaka O; Takeshima Y; Awaya H; Kushitani K; Kohno N; Inai K
Pathol Int; 2005 Jun; 55(6):303-9. PubMed ID: 15943786
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors.
Bello MJ; Alonso ME; Amiñoso C; Anselmo NP; Arjona D; Gonzalez-Gomez P; Lopez-Marin I; de Campos JM; Gutierrez M; Isla A; Kusak ME; Lassaletta L; Sarasa JL; Vaquero J; Casartelli C; Rey JA
Mutat Res; 2004 Oct; 554(1-2):23-32. PubMed ID: 15450401
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional repression of O6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N'-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells.
Ma LC; Kuo CC; Liu JF; Chen LT; Chang JY
Mol Pharmacol; 2008 Aug; 74(2):517-26. PubMed ID: 18492797
[TBL] [Abstract][Full Text] [Related]
33. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA
Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078
[TBL] [Abstract][Full Text] [Related]
34. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
[TBL] [Abstract][Full Text] [Related]
35. High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.
Jesien-Lewandowicz E; Jesionek-Kupnicka D; Zawlik I; Szybka M; Kulczycka-Wojdala D; Rieske P; Sieruta M; Jaskolski D; Och W; Skowronski W; Sikorska B; Potemski P; Papierz W; Liberski PP; Kordek R
Cancer Genet Cytogenet; 2009 Jan; 188(2):77-82. PubMed ID: 19100509
[TBL] [Abstract][Full Text] [Related]
36. Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy.
Mineura K; Yanagisawa T; Watanabe K; Kowada M; Yasui N
Int J Cancer; 1996 Oct; 69(5):420-5. PubMed ID: 8900378
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
[TBL] [Abstract][Full Text] [Related]
38. "MGMT for pt mgmt": is methylguanine-DNA methyltransferase testing ready for patient management?
Iafrate AJ; Louis DN
J Mol Diagn; 2008 Jul; 10(4):308-10. PubMed ID: 18556768
[TBL] [Abstract][Full Text] [Related]
39. MGMT promoter methylation status in anaplastic meningiomas.
Brokinkel B; Fischer BR; Peetz-Dienhart S; Ebel H; Sepehrnia A; Rama B; Albert FK; Stummer W; Paulus W; Hasselblatt M
J Neurooncol; 2010 Dec; 100(3):489-90. PubMed ID: 20449628
[No Abstract] [Full Text] [Related]
40. Ascorbate content of clinical glioma tissues is related to tumour grade and to global levels of 5-hydroxymethyl cytosine.
Crake RLI; Burgess ER; Wiggins GAR; Magon NJ; Das AB; Vissers MCM; Morrin HR; Royds JA; Slatter TL; Robinson BA; Phillips E; Dachs GU
Sci Rep; 2022 Sep; 12(1):14845. PubMed ID: 36050369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
